0.45Open0.45Pre Close0 Volume1 Open Interest0.50Strike Price0.00Turnover4855.47%IV44.44%PremiumDec 20, 2024Expiry Date0.41Intrinsic Value100Multiplier1DDays to Expiry0.04Extrinsic Value100Contract SizeAmericanOptions Type-0.3865Delta1.9692Gamma0.20Leverage Ratio-0.0534Theta0.0000Rho-0.08Eff Leverage0.0000Vega
Eyenovia Stock Discussion
1. To approve a proposed amendment to the Eyenovia, Inc. Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of our issued and outstanding shares of common stock, 0.0001 par value per share (the “common stock”), at a ratio of between 1:40 and 1:80 (the “Reverse Stock Split Amendment”);
EYEN
(“Eyenovia” or the “Company”), an ophthalmic technology company developing and commercializing advanced products leveraging its proprietary Optejet topical ophthalmic medication dispensing platform, today announced that it has entered into a securities purchase agreement with a healthcare focused institutional investor for the purchase and sale of 20,085,025 shares of its common stock (or common stock equivalen...
9/10s of a K @ $0.092 now waiting game
No comment yet